Hemodialysis. Chronic kidney disease, stage 5
Conditions
Interventions
Intervention 1: For intervention group patient, BASNEF-based empowerment program is performed by researchers. Intervention method so that Patients in groups (least 8 people and maximum 15 people) in 8
Behavior
Lifestyle
For intervention group patient, BASNEF-based empowerment program is performed by researchers. Intervention method so that Patients in groups (least 8 people and maximum 15 people) in 8 sessions 60 min
Patients in the control group underwent routine cares and educations and them will gave the hemodialysis patients special educational pamphlet.
Sponsors
Kashan University of Medical Sciences, Vice Chancellor of Research & Technology
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: 1. Patients treated with chronic hemodialysis according to specialist diagnosis. 2. Willingness to participate in research. 3. Aged 18 to 65 years. 4. A history of well-known mental problems and kidney transplant is not. 5. Known cognitive problems including Alzheimer's disease, stroke, transient ischemic attack and hearing and vision loss to the extent that they cannot read or write; not suffered. 6. Physical and mental ability have to participate in empowerment meetings and be able to talk. 7. The caregiver is an important person for studying person and trust and confidence family and relatives his/her that directly involved in patient care. Exclusion criteria: 1. Dissatisfaction with continuation of cooperation with the study for any reason and at any phase 2. The absence in two or more sessions in the research program. 3. Outbreak debilitating complications of the disease. 4. Studying person died during the study.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| General health. Timepoint: At baseline and a week after the last session implantation in the intervention group and after a month of the start of the study in the control group. Method of measurement: Goldberg's General Health Questionnaire?.;Self-efficacy. Timepoint: At baseline and a week after the last session implantation in the intervention group and after a month of the start of the study in the control group. Method of measurement: Sherer's General Self-Efficacy Scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammad Aghajani
Kashan University of Medical Sciences
Outcome results
None listed